Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Gynecologic Oncology
|
January 23, 2017
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers
Kim A Reiss, Joseph M Herman, Deborah Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2010
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer
Karen Lim, William Small, Lorraine Portelance, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2015
Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis
David Peterson, Pauline T Truong, Sameer Parpia, et al.
Lancet (London, England)
|
December 10, 2019
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial
Timothy J Whelan, Jim A Julian, Tanya S Berrang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 27, 2024
Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer
Melanie Dawe, Wei Shi, Tian Y Liu, et al.
The Lancet. Oncology
|
July 12, 2016
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
British Journal of Cancer
|
January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2020
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, et al.
Journal of the National Cancer Institute
|
October 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis
Per Karlsson, Anthony Fyles, S Laura Chang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
Bastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Gynecologic Oncology
|
January 23, 2017
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers
Kim A Reiss, Joseph M Herman, Deborah Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2010
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer
Karen Lim, William Small, Lorraine Portelance, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2015
Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis
David Peterson, Pauline T Truong, Sameer Parpia, et al.
Lancet (London, England)
|
December 10, 2019
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial
Timothy J Whelan, Jim A Julian, Tanya S Berrang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 27, 2024
Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer
Melanie Dawe, Wei Shi, Tian Y Liu, et al.
The Lancet. Oncology
|
July 12, 2016
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
British Journal of Cancer
|
January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2020
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, et al.
Journal of the National Cancer Institute
|
October 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis
Per Karlsson, Anthony Fyles, S Laura Chang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
Bastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.
Page
of 14